MERSCOPE run 2: Left lung sample 7101 overview. To better understand lung maintenance and how it can progress to disease, postdoctoral fellow Laura Crowley, PhD, wants to know how different cell types ...
CAMBRIDGE, Mass., June 17, 2025--(BUSINESS WIRE)--Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced the publication of a study in Nature Neuroscience that showcases ...
The December 2 MERSCOPE User Group Meeting was a dynamic morning of talks and networking focused on advances in spatial transcriptomics. Peter Reinhold, Senior Product Manager at Vizgen welcomed ...
WALTHAM, Mass., June 08, 2026--(BUSINESS WIRE)--Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch ...
Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers Vizgen, ...
Imaging-based single-molecule spatial transcriptomics is dominated by three platforms: 10x Genomics' Xenium, the CosMx Spatial Molecular Imager (SMI), and MERSCOPE. Each images RNA transcripts ...
Cell atlasing efforts rest on a deceptively simple premise: To understand a tissue, you must find every cell in it, including the rare populations and transitional states whose biology is often the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results